DuPont Proxy Fight Comes to a Head as Shareholders Meet Today

An activist battle is brewing at DuPont's (DD) Delaware Headquarters today. The battle for the chemical company's future will reach the climax when shareholders learn whether the company was able to hold off a power grab by activist investor Nelson Peltz. Peltz's Trian Management Hedge Fund has nominated 4 candidates, including himself, to Dupont's Board of Directors. Peltz has advocated splitting DuPont into two companies, cutting costs, increasing leverage and divesting some assets. CEO Ellen Kullman has fought Peltz's proxy war, saying his plan would destroy shareholder value and gut the company research and development.